Nordson (NDSN) PT Raised to $287 at Baird
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall St to open lower as oil spikes after Trump rejects Iran peace proposal
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
- Oppenheimer sees AI software winners as focus shifts to ROI
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Cantor Fitzgerald Starts Lexicon Pharmaceuticals (LXRX) at Overweight
- Nvidia releases AI safety software it says could have stopped Hugging Face hack
- Trump says men arrested at UK air base used by US were looking to do 'big damage'
Nordson Corporation Reports Third Quarter Fiscal 2024 Results and Updates Annual Guidance
August 21, 2024 4:30 PM EDTThird Quarter Highlights:
Sales were $662 million, an increase of 2% year-over-year and in-line with mid-point of guidance Earnings per diluted share were $2.04 Adjusted earnings per diluted share were $2.41, $0.08 above the mid-point of guidanceUpdated Full-Year Guidance:
Increasing full fiscal year 2024 revenue guidance to reflect the addition of Atrion acquisition Maintaining full fiscal year 2024 adjusted earnings per diluted share guidance, inclusive of the slightly dilutive fourth quarter Atrion acquisition impactWESTLAKE,... More
Nordson Corporation Completes Acquisition of Atrion Corporation
August 21, 2024 8:35 AM EDTWESTLAKE, Ohio--(BUSINESS WIRE)-- Nordson Corporation (Nasdaq: NDSN) (the Company or Nordson) has completed the acquisition of Atrion Corporation (Atrion), a leader in proprietary medical infusion fluid delivery and niche cardiovascular solutions. The completion of the transaction follows the Companys May 28, 2024 announcement that it had entered into an agreement to acquire the business. This acquisition will expand Nordsons medical... More

